False positives in multiplex PCR-based next-generation sequencing have unique signatures.

Chad M McCall1, Stacy Mosier1, Michele Thiess1

  • 1Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Summary

Next-generation sequencing (NGS) can detect false mutations in cancer gene panels. Careful analysis is needed to distinguish true mutations from artifacts caused by multiplex PCR primer mispriming.